Received Dec 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | SYR / RA |
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | — | PO / MO |
Patient received the rotavirus vaccine and stopped passing bowel movements immediately afterward. We took patient to emergency room the next day and was advised to stimulate bowel movements using a suppository. For months patient would only pass bowel movements if stimulated. Prior to the vaccine patient had steady, consistent bowel movements. Patient was seen by several gastro specialists. Patient still suffers from constipation to this day.
None
None
None
None
Was checked for intussusception by ultrasound and a contrast enema with negative results.